125 related articles for article (PubMed ID: 38014701)
1. Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway.
Yuan J; Chang Y; Dai Y; Chen Y; Yue R; Zeng L
Neoplasma; 2023 Dec; 70(6):747-760. PubMed ID: 38014701
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.
Li Y; Wang LX; Pang P; Cui Z; Aung S; Haley D; Fox BA; Urba WJ; Hu HM
Clin Cancer Res; 2011 Nov; 17(22):7047-57. PubMed ID: 22068657
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-derived autophagosomes (DRibbles)-activated B cells induce specific naïve CD8
Zhang TY; Ren HY; Pan N; Dong HX; Zhao SM; Wen ZF; Wang XR; Wang LX
Cancer Immunol Immunother; 2021 Feb; 70(2):463-474. PubMed ID: 32809049
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Antitumor Efficacy of Cancer Stem Cell-Derived DRibble Vaccine on Colorectal Carcinoma.
Fu C; Tian G; Duan J; Liu K; Zhang C; Yan W; Wang Y
Int J Med Sci; 2021; 18(14):3249-3260. PubMed ID: 34400894
[TBL] [Abstract][Full Text] [Related]
5. Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression.
Yu G; Li Y; Cui Z; Morris NP; Weinberg AD; Fox BA; Urba WJ; Wang L; Hu HM
Sci Rep; 2016 Nov; 6():37558. PubMed ID: 27874054
[TBL] [Abstract][Full Text] [Related]
6. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles).
Xing Y; Cao R; Hu HM
Cell Death Dis; 2016 Aug; 7(8):e2322. PubMed ID: 27490927
[TBL] [Abstract][Full Text] [Related]
7. Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.
Dong H; Wen ZF; Chen L; Zhou N; Liu H; Dong S; Hu HM; Mou Y
Int J Nanomedicine; 2018; 13():3353-3365. PubMed ID: 29922056
[TBL] [Abstract][Full Text] [Related]
8. Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinoma.
Dong H; Su H; Chen L; Liu K; Hu HM; Yang W; Mou Y
Cancer Manag Res; 2018; 10():493-501. PubMed ID: 29588618
[TBL] [Abstract][Full Text] [Related]
9. IFN-DC Loaded with Autophagosomes containing Virus Antigen is Highly Efficient in Inducing Virus-Specific Human T Cells.
Fan J; Wu Y; Jiang M; Wang L; Yin D; Zhang Y; Ye W; Yi Y
Int J Med Sci; 2019; 16(5):741-750. PubMed ID: 31217742
[TBL] [Abstract][Full Text] [Related]
10. Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models.
Zhang R; Yuan F; Shu Y; Tian Y; Zhou B; Yi L; Zhang X; Ding Z; Xu H; Yang L
Cancer Immunol Immunother; 2020 Jan; 69(1):135-145. PubMed ID: 31807878
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer.
Su H; Luo Q; Xie H; Huang X; Ni Y; Mou Y; Hu Q
Int J Nanomedicine; 2015; 10():1921-30. PubMed ID: 25792826
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine.
Aldarouish M; Wang H; Zhou M; Hu HM; Wang LX
J Exp Clin Cancer Res; 2015 Apr; 34(1):34. PubMed ID: 25886865
[TBL] [Abstract][Full Text] [Related]
13. Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination.
Hulett TW; Jensen SM; Wilmarth PA; Reddy AP; Ballesteros-Merino C; Afentoulis ME; Dubay C; David LL; Fox BA
J Immunother Cancer; 2018 Apr; 6(1):27. PubMed ID: 29618380
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Derived Autophagosomes (DRibbles) Activate Human B Cells to Induce Efficient Antigen-Specific Human Memory T-Cell Responses.
Ren H; Zhang T; Wang Y; Yao Q; Wang Z; Zhang L; Wang L
Front Immunol; 2021; 12():675822. PubMed ID: 34122437
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism.
Patel JM; Cui Z; Wen ZF; Dinh CT; Hu HM
J Immunother Cancer; 2019 Nov; 7(1):311. PubMed ID: 31747946
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic antitumor efficacy of B cells loaded with tumor-derived autophagasomes vaccine (DRibbles).
Ren H; Zhao S; Li W; Dong H; Zhou M; Cao M; Hu HM; Wang LX
J Immunother; 2014 Oct; 37(8):383-93. PubMed ID: 25198526
[TBL] [Abstract][Full Text] [Related]
17. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
[TBL] [Abstract][Full Text] [Related]
18. Engineering neoantigen vaccines to improve cancer personalized immunotherapy.
Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X
Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174
[TBL] [Abstract][Full Text] [Related]
19. High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
Hernandez R; LaPorte KM; Hsiung S; Santos Savio A; Malek TR
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34475132
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer vaccines: Tumor-associated antigens
Wagner S; Mullins CS; Linnebacher M
World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
